These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2757652)

  • 1. Effect of inhibition of protein synthesis on cholestasis induced by taurolithocholate, lithocholate, and a manganese-bilirubin combination in the rat.
    Dahlström-King L; Plaa GL
    Biochem Pharmacol; 1989 Aug; 38(15):2543-9. PubMed ID: 2757652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of taurine on the cholestatic potential of sulfated lithocholate and its conjugates.
    Belli DC; Roy CC; Fournier LA; Tuchweber B; Giguère R; Yousef IM
    Liver; 1991 Jun; 11(3):162-9. PubMed ID: 1886461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tauroursodeoxycholate prevents taurolithocholate-induced cholestasis and toxicity in rat liver.
    Schölmerich J; Baumgartner U; Miyai K; Gerok W
    J Hepatol; 1990 May; 10(3):280-3. PubMed ID: 2365980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of taurolithocholate on in vivo sulfation and glucuronidation of acetaminophen in rats.
    Galinsky RE; Chałasinska B
    Pharm Res; 1988 Jan; 5(1):61-4. PubMed ID: 3244612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatic Na +, K + -adenosinetriphosphatase in taurolithocholate-induced cholestasis in the rat.
    Reichen J; Paumgartner G
    Experientia; 1979 Sep; 35(9):1186-8. PubMed ID: 226396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of lithocholate- and taurolithocholate-induced intrahepatic cholestasis in rats.
    Kakis G; Yousef IM
    Gastroenterology; 1978 Oct; 75(4):595-607. PubMed ID: 213342
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduced cholestatic potency of taurolithocholate during backward perfusion of the rat liver.
    Baumgartner U; Hardison WG; Miyai K
    Lab Invest; 1987 Jun; 56(6):576-82. PubMed ID: 3599905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestasis induced by lithocholate and its glucuronide: their biliary excretion and metabolism.
    Takikawa H; Ohki H; Sano N; Kasama T; Yamanaka M
    Biochim Biophys Acta; 1991 Jan; 1081(1):39-44. PubMed ID: 1991154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of severity of bile flow reduction, cycloheximide, and methyl isobutyl ketone pretreatment on the kinetics of taurolithocholic acid disposition in the rat.
    Dahlström-King L; du Souich P; Couture J; Plaa GL
    Toxicol Appl Pharmacol; 1990 Jun; 104(2):312-21. PubMed ID: 2363182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic administration of taurolithocholate on bile formation and liver ultrastructure in the rat.
    Gratton F; Weber AM; Tuchweber B; Morazain R; Roy CC; Yousef IM
    Liver; 1987 Jun; 7(3):130-7. PubMed ID: 3613882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurolithocholate-induced intrahepatic cholestasis: potentiation by methyl isobutyl ketone and methyl n-butyl ketone in rats.
    Plaa GL; Ayotte P
    Toxicol Appl Pharmacol; 1985 Sep; 80(2):228-34. PubMed ID: 4024113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurohyocholate, taurocholate, and tauroursodeoxycholate but not tauroursocholate and taurodehydrocholate counteract effects of taurolithocholate in rat liver.
    Schölmerich J; Kitamura S; Baumgartner U; Miyai K; Gerok W
    Res Exp Med (Berl); 1990; 190(2):121-9. PubMed ID: 2349395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taurolithocholate-induced increase in the intrabiliary pressure generated during retrograde intrabiliary infusion of saline in rats: antagonism by taurocholate and glycocholate.
    Jansen MA; Olson JR; Fujimoto JM
    Toxicol Appl Pharmacol; 1980 Jun; 54(1):9-19. PubMed ID: 7394789
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentiation by methyl isobutyl ketone of the cholestasis induced in rats by a manganese-bilirubin combination or manganese alone.
    Vézina M; Plaa GL
    Toxicol Appl Pharmacol; 1987 Dec; 91(3):477-83. PubMed ID: 3424376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of lithocholate--induced cholestasis by cycloheximide, an inhibitor of protein synthesis.
    Yousef IM; Tuchweber B; Weber A
    Life Sci; 1983 Jul; 33(1):103-10. PubMed ID: 6865646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of lithocholic-acid-induced cholestasis by methyl isobutyl ketone.
    Joseph LD; Yousef IM; Plaa GL; Sharkawi M
    Toxicol Lett; 1992 Jun; 61(1):39-47. PubMed ID: 1609437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological aspects of manganese-bilirubin induced cholestasis.
    de Lamirande E; Tuchweber B; Plaa GL
    Liver; 1982 Mar; 2(1):22-7. PubMed ID: 7176835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurolithocholate increases heme catabolism and alters the clearance of antipyrine in the rat.
    Berry WR; Kirshenbaum G; Hoilien C; Le M; Reichen J
    Gastroenterology; 1985 Feb; 88(2):397-402. PubMed ID: 3965329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic subcellular distribution of manganese in manganese and manganese-bilirubin induced cholestasis.
    Ayotte P; Plaa GL
    Biochem Pharmacol; 1985 Nov; 34(21):3857-65. PubMed ID: 4062960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cultures of rat hepatocytes as a model system of canalicular development, biliary secretion, and intrahepatic cholestasis. II. Taurolithocholate-induced alterations of canalicular morphology and of the distribution of filipin-cholesterol complexes.
    Jung W; Gebhardt R; Robenek H
    Eur J Cell Biol; 1982 Nov; 29(1):77-82. PubMed ID: 7151828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.